Volume 20 - Issue 4 - April 2007
New Products »
Technology In Practice »
I avoided the politics of podiatry for most of the first 20 years of practice. I considered all the American Podiatric Medical Association (APMA) stuff that went on in Washington, D.C. a waste of time and money although I have been a card-carrying member since 1975.
I got my first taste of leadership in our profession in 1993 when I became a member of the Washington Podiatric Medical Licensing Board. The work was challenging and fulfilling.
News and Trends »
While some have touted surgical decompression as a possible treatment option for diabetic sensorimotor polyneuropathy (DPN), authors of a recent Diabetes Care commentary have challenged the validity of this procedure, calling it an unproven modality based on flawed hypotheses.
I am writing in response to the recent feature article, “How To Provide Physical Therapy As An Ancillary Service,” written by Jonathan Moore, DPM (see pg. 36, February issue). Unfortunately, the article may lead some readers to believe that adding physical therapist services to a physician/medical practice is not without potential harm or controversy.
Diabetes Watch »
Do islet cells hold promise in treating diabetes? Islet cells are groupings of hormone-secreting cells in the pancreas that are responsible for several endocrine functions including the production of insulin. Pancreatic islets contain four different types of cells including: insulin-producing beta cells, glucagon-releasing alpha cells, somatostatin-producing delta cells and cells that contain polypeptides (PP cells). Each individual islet contains approximately 1,000 of these four types of cells.